Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-021764
Filing Date
2026-05-07
Accepted
2026-05-07 17:17:09
Documents
64
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 859773
2 EX-31.1 ex31-1.htm EX-31.1 18654
3 EX-31.2 ex31-2.htm EX-31.2 18624
4 EX-32.1 ex32-1.htm EX-32.1 13046
5 GRAPHIC form10-q_001.jpg GRAPHIC 281475
  Complete submission text file 0001493152-26-021764.txt   5973254

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE immx-20260331.xsd EX-101.SCH 42688
7 XBRL CALCULATION FILE immx-20260331_cal.xml EX-101.CAL 54554
8 XBRL DEFINITION FILE immx-20260331_def.xml EX-101.DEF 158094
9 XBRL LABEL FILE immx-20260331_lab.xml EX-101.LAB 405931
10 XBRL PRESENTATION FILE immx-20260331_pre.xml EX-101.PRE 309188
67 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 723442
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41159 | Film No.: 26954888
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)